Clinical Trial Update: Intravenous Brincidofovir as an Antiviral for Treatment of Progressive Multifocal Leukoencephalopathy: A Pilot Study [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating intravenous brincidofovir for progressive multifocal leukoencephalopathy is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multifocal Leukoencephalopathy

Drugs mentioned

• Brincidofovir (brincidofovir)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Progressive Multifocal Leukoencephalopathy | Phase 2 | Status: NOT_YET_RECRUITING